Geneos Wealth Management’s ProShares Ultra Real Estate URE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-69,721
Closed -$8.1M 2989
2021
Q4
$8.1M Buy
+69,721
New +$7.15M 0.31% 64
2020
Q1
Sell
-284
Closed -$24K 2610
2019
Q4
$24K Sell
284
-71,526
-100% -$6.15M ﹤0.01% 1609
2019
Q3
$6.25M Sell
71,810
-8,580
-11% -$709K 0.37% 63
2019
Q2
$6.18M Buy
80,390
+4,027
+5% +$308K 0.38% 61
2019
Q1
$5.81M Buy
+76,363
New +$5.21M 0.38% 62
2018
Q4
Sell
-54,912
Closed -$3.59M 2486
2018
Q3
$3.59M Buy
+54,912
New +$3.68M 0.24% 123
2017
Q3
Sell
-18,788
Closed -$1.18M 2153
2017
Q2
$1.18M Buy
+18,788
New +$1.16M 0.12% 165
2016
Q3
Sell
-2,740
Closed -$175K 2000
2016
Q2
$175K Buy
2,740
+296
+12% +$17K 0.03% 473
2016
Q1
$138K Buy
+2,444
New +$119K 0.02% 510

Other funds holding URE

Geneos Wealth Management's URE Position: Q1 2022 in Review

Geneos Wealth Management sold out of ProShares Ultra Real Estate (URE) in Q1 2022, closing a stake of 69,721 shares — an estimated $8.1M sold.

Geneos Wealth Management first reported a position in URE in Q1 2016 and held it in 9 quarters. The position peaked at $8.1M in Q4 2021. 20 funds tracked by Wall St. Rank hold URE as of Q1 2022.

  • Geneos Wealth Management reported no remaining ProShares Ultra Real Estate position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 69,721 ProShares Ultra Real Estate shares in Q1 2022, an estimated $8.1M.
  • Geneos Wealth Management first reported a position in ProShares Ultra Real Estate in Q1 2016 and held it in 9 quarters.
  • Geneos Wealth Management's ProShares Ultra Real Estate position peaked at $8.1M in Q4 2021.
  • 20 funds tracked by Wall St. Rank held ProShares Ultra Real Estate as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.